Table 5 Differences in donor and recipient characteristics between the derivation and validation datasets (P-values, χ2 tests and ANOVA when appropriate).
From: A Donor Quality Index for liver transplantation: development, internal and external validation
Recipient characteristics | 2009–2013 (n = 3961) | 2014 (n = 1048) | P- values |
|---|---|---|---|
Expert component (no) | 3248 (82%) | 874 (83.4%) | 0.31 |
ABO group | 0.59 | ||
A | 1800 (45.44%) | 465 (44.37%) | |
AB | 173 (4.37%) | 38 (3.63%) | |
B | 442 (11.16%) | 118 (11.26%) | |
O | 1546 (39.03%) | 427 (40.74%) | |
Re-transplantation (no) | 3621 (91.42%) | 961 (91.7%) | 0.82 |
On dialysis (no) | 3750 (94.67%) | 987 (94.18%) | 0.58 |
Medical condition before LT | 0.45 | ||
Home | 2710 (68.42%) | 705 (67.27%) | |
Hosptial | 550 (13.89%) | 140 (13.36%) | |
ICU | 701 (17.7%) | 203 (19.37%) | |
Hepatitis C virus antibody (−) | 3017 (76.17%) | 811 (77.39%) | 0.43 |
Diabetes (no) | 3063 (77.33%) | 793 (75.67%) | 0.27 |
Decompensated cirrhosis (no) | 2466 (62.26%) | 667 (63.65%) | 0.43 |
Donor characteristics | 2009–2013 (n = 3961) | 2014 (n = 1048) | P-values |
ABO group | 0.75 | ||
A | 1766 (44.58%) | 460 (43.89%) | |
AB | 143 (3.61%) | 32 (3.05%) | |
B | 391 (9.87%) | 102 (9.73%) | |
O | 1661 (41.93%) | 454 (43.32%) | |
Age | <0.01 | ||
≤69 | 3029 (76.47%) | 710 (67.75%) | |
>69 | 932 (23.53%) | 338 (32.25%) | |
COD | <0.01 | ||
Anoxia | 476 (12.02%) | 150 (14.31%) | |
CVA | 2388 (60.29%) | 651 (62.12%) | |
Trauma | 976 (24.64%) | 231 (22.04%) | |
Other | 121 (3.05%) | 16 (1.53%) | |
ICU stay (in days) | |||
<4 | 3156 (79.68%) | 853 (81.39%) | |
>4 | 805 (20.32%) | 195 (18.61%) | |
Clearance MDRD: lowest (ml/min/1.73 m2) | |||
<60 | 1400 (35.34%) | 385 (36.74%) | |
60–89 | 1459 (36.83%) | 388 (37.02%) | |
>90 | 1102 (27.82%) | 275 (26.24%) | |
Liver type (entire) | 3759 (94.9%) | 1007 (96.09%) | 0.13 |
